Finland: A framework for genetic research
Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.
How battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells
Dr Carlos Ziebert, head of IAM-AWP’s Calorimeter Center, KIT, explains how battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells.
A gateway to transport and energy research: The Innovation and Networks Executive Agency
Dirk Beckers, Director of the Innovation and Networks Executive Agency, charts the important work of the organisation in supporting transport and energy research plus the ambitious Horizon Europe research and innovation framework programme (2021-2027).
Could placenta cells save patients with severe COVID-19?
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
Dementia gene doubles risk of developing severe COVID-19
Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.
Targeting immune mechanisms underlying cardiovascular diseases
János G. Filep, MD from the University of Montreal and Maisonneuve-Rosemont Hospital in Canada, discusses targeting immune mechanisms underlying cardiovascular diseases.
COVID-19 patients may be susceptible to developing subacute thyroiditis
The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
Chemistry: Microfluidic devices for detecting pain
Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
How are advanced materials part of the solution to our global challenges?
Philippe JACQUES, Managing Director of EMIRI, explores how advanced materials can be used to solve global challenges such as the current COVID-19 pandemic.
Can nanotechnology aid the battle against COVID-19?
Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explores if nanotechnology aids the battle against COVID-19.
Modeling the whole-body dynamics of SARS-CoV-2 to investigate treatment strategies for effective management of...
Prashant Dogra1, Kavya Sinha2, Zhihui Wang1, Vittorio Cristini1,*
1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas
2Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart...
Over 25% of the UK have already had COVID-19
Researchers from The University of Manchester, Salford Royal and Res Consortium prove that over 25% of the UK are likely to have contracted COVID-19 already.
The NIDCR: Advancing America’s oral health through research and innovation
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
What is the lockdown impact on alcohol intake, gambling and porn use?
One of the key questions is soon to be answered by researchers, who will track lockdown impact on alcohol intake, gambling habits and porn watching.
Subsurface sampling using High-Velocity impactors
Here, R.M Winglee and M. Danner, Department of Earth and Space Sciences, University of Washington, discuss robotic exploration and High-Velocity Impactors.
Umbilical cord stem cells have the potential to treat COVID-19
Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery.
Chemistry research: Driving discovery and development
The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
Existing drugs should be used to treat COVID-19 instead of vaccine
Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
COVID-19 Volunteer Testing Network: Screening healthcare workers
Mike Fischer CBE, Founder of the COVID-19 Volunteer Testing Network, details the work being done to keep healthcare workers safe on the frontline and provide regular screening for COVID-19.
Scientists design novel chemical compounds using AI to combat SARS-CoV-2
Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
